Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Chronic phencyclidine increases synapsin-1 and synaptic adaptation proteins in the medial prefrontal cortex.

Pickering C, Ericson M, Söderpalm B.

ISRN Psychiatry. 2013 Feb 19;2013:620361. doi: 10.1155/2013/620361. Print 2013.

2.

Repeated ethanol but not phencyclidine impairs spontaneous alternation behaviour in the Y-maze.

Götesson J, Ericson M, Söderpalm B, Pickering C.

Basic Clin Pharmacol Toxicol. 2012 Apr;110(4):347-52. doi: 10.1111/j.1742-7843.2011.00819.x. Epub 2011 Nov 9.

3.

Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs.

Cochran SM, Kennedy M, McKerchar CE, Steward LJ, Pratt JA, Morris BJ.

Neuropsychopharmacology. 2003 Feb;28(2):265-75.

4.
5.

Disruption of medial prefrontal synchrony in the subchronic phencyclidine model of schizophrenia in rats.

Young AM, Stubbendorff C, Valencia M, Gerdjikov TV.

Neuroscience. 2015 Feb 26;287:157-63. doi: 10.1016/j.neuroscience.2014.12.014. Epub 2014 Dec 24.

6.

Effects of N-acetylaspartylglutamate (NAAG) peptidase inhibition on release of glutamate and dopamine in prefrontal cortex and nucleus accumbens in phencyclidine model of schizophrenia.

Zuo D, Bzdega T, Olszewski RT, Moffett JR, Neale JH.

J Biol Chem. 2012 Jun 22;287(26):21773-82. doi: 10.1074/jbc.M112.363226. Epub 2012 May 8.

7.

The role of the hippocampo-prefrontal cortex system in phencyclidine-induced psychosis: a model for schizophrenia.

Jodo E.

J Physiol Paris. 2013 Dec;107(6):434-40. doi: 10.1016/j.jphysparis.2013.06.002. Epub 2013 Jun 17. Review.

PMID:
23792022
8.

Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat.

Abdul-Monim Z, Neill JC, Reynolds GP.

J Psychopharmacol. 2007 Mar;21(2):198-205. Erratum in: J Psychopharmacol. 2008 Aug;22(6):698.

PMID:
17329300
9.

Ethanol impairment of spontaneous alternation behaviour and associated changes in medial prefrontal glutamatergic gene expression precede putative markers of dependence.

Pickering C, Alsiö J, Morud J, Ericson M, Robbins TW, Söderpalm B.

Pharmacol Biochem Behav. 2015 Mar 2;132:63-70. doi: 10.1016/j.pbb.2015.02.021. [Epub ahead of print]

PMID:
25743187
10.

Similarities in the behavior and molecular deficits in the frontal cortex between the neurotensin receptor subtype 1 knockout mice and chronic phencyclidine-treated mice: relevance to schizophrenia.

Li Z, Boules M, Williams K, Gordillo A, Li S, Richelson E.

Neurobiol Dis. 2010 Nov;40(2):467-77. doi: 10.1016/j.nbd.2010.07.011. Epub 2010 Jul 24.

12.

The atypical antipsychotic drug clozapine enhances chronic PCP-induced regulation of prefrontal cortex 5-HT2A receptors.

Steward LJ, Kennedy MD, Morris BJ, Pratt JA.

Neuropharmacology. 2004 Sep;47(4):527-37.

PMID:
15380371
13.

Involvement of gamma-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex.

Yonezawa Y, Kuroki T, Kawahara T, Tashiro N, Uchimura H.

Eur J Pharmacol. 1998 Jan 2;341(1):45-56.

PMID:
9489855
14.
15.

Acute phencyclidine treatment induces extensive and distinct protein phosphorylation in rat frontal cortex.

Palmowski P, Rogowska-Wrzesinska A, Williamson J, Beck HC, Mikkelsen JD, Hansen HH, Jensen ON.

J Proteome Res. 2014 Mar 7;13(3):1578-92. doi: 10.1021/pr4010794. Epub 2014 Feb 24.

PMID:
24564430
16.

Phencyclidine-induced loss of asymmetric spine synapses in rodent prefrontal cortex is reversed by acute and chronic treatment with olanzapine.

Elsworth JD, Morrow BA, Hajszan T, Leranth C, Roth RH.

Neuropsychopharmacology. 2011 Sep;36(10):2054-61. doi: 10.1038/npp.2011.96. Epub 2011 Jun 15.

17.

Phencyclidine (PCP)-induced disruption in cognitive performance is gender-specific and associated with a reduction in brain-derived neurotrophic factor (BDNF) in specific regions of the female rat brain.

Snigdha S, Neill JC, McLean SL, Shemar GK, Cruise L, Shahid M, Henry B.

J Mol Neurosci. 2011 Mar;43(3):337-45. doi: 10.1007/s12031-010-9447-5. Epub 2010 Sep 18.

18.

Neurochemical changes in the rat prefrontal cortex following acute phencyclidine treatment: an in vivo localized (1)H MRS study.

Iltis I, Koski DM, Eberly LE, Nelson CD, Deelchand DK, Valette J, Ugurbil K, Lim KO, Henry PG.

NMR Biomed. 2009 Aug;22(7):737-44. doi: 10.1002/nbm.1385.

19.

Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia.

Santini MA, Ratner C, Aznar S, Klein AB, Knudsen GM, Mikkelsen JD.

J Neurosci Res. 2013 May;91(5):634-41. doi: 10.1002/jnr.23198. Epub 2013 Feb 13.

PMID:
23404493
20.

Supplemental Content

Support Center